1. Home
  2. SHO vs PHVS Comparison

SHO vs PHVS Comparison

Compare SHO & PHVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sunstone Hotel Investors Inc. Sunstone Hotel Investors Inc.

SHO

Sunstone Hotel Investors Inc. Sunstone Hotel Investors Inc.

N/A

Current Price

$12.77

Market Cap

2.3B

ML Signal

N/A

Logo Pharvaris N.V.

PHVS

Pharvaris N.V.

N/A

Current Price

$33.50

Market Cap

2.4B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SHO
PHVS
Founded
1995
2015
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Hotels/Resorts
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.3B
2.4B
IPO Year
2004
2020

Fundamental Metrics

Financial Performance
Metric
SHO
PHVS
Price
$12.77
$33.50
Analyst Decision
Hold
Strong Buy
Analyst Count
12
14
Target Price
$12.40
★ $57.82
AVG Volume (30 Days)
★ 3.1M
621.8K
Earning Date
11-06-2026
11-12-2026
Dividend Yield
★ 2.83%
N/A
EPS Growth
N/A
★ N/A
EPS
★ 0.43
N/A
Revenue
★ $1,115,167,000.00
N/A
Revenue This Year
$4.56
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$29.64
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$8.69
$23.01
52 Week High
$13.08
$43.25

Technical Indicators

Market Signals
Indicator
SHO
PHVS
Relative Strength Index (RSI) 60.39 52.95
Support Level $12.19 $32.27
Resistance Level $13.08 $36.36
Average True Range (ATR) 0.28 1.50
MACD -0.05 0.15
Stochastic Oscillator 61.80 49.74

Price Performance

Historical Comparison
SHO
PHVS

About SHO Sunstone Hotel Investors Inc. Sunstone Hotel Investors Inc.

Sunstone Hotel Investors Inc is a real estate investment trust that acquires, owns, manages, and renovates the full-service hotel and select-service hotel properties across various states in the United States. Its firm's portfolio consists upper upscale and luxury hotels located in convention, resort destination and urban markets. Its majority of the hotels operate under a brand owned by Marriott, Hilton, Hyatt, Four Seasons or Montage. It operates geographically in California which generates the majority of its revenue; Florida; and Hawaii. The company's sole source of income is hotel revenue from its Hotel Ownership Segment.

About PHVS Pharvaris N.V.

Pharvaris NV is a late-stage biopharmaceutical company which is engaged in developing novel, oral bradykinin B2 receptor antagonists to prevent and treat HAE attacks. By directly pursuing this clinically therapeutic target with novel small molecules, With positive data in both Phase 2 prophylaxis and studies in HAE, Pharvaris is developing deucrictibant. Pharvaris is currently enrolling a pivotal Phase 3 study for the treatment of HAE attacks and plans to initiate a pivotal Phase 3 study of deucrictibant for the prevention of HAE attacks. The company is also running open-label extension studies in both on-demand (RAPIDe-2) and prophylactic (CHAPTER-4) settings to collect long-term safety and efficacy data in HAE patients.

Share on Social Networks: